Healthcare Of Ontario Pension Plan Trust Fund Biomarin Pharmaceutical Inc Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 21, 2024	BUY	$76.22 - $98.51 $4.05 Million - $5.23 Million	53,087 New	53,087 $5.12 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $770,931 - $892,068	8,894 New	8,894 $770,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $566,510 - $760,410	-7,000 Reduced 17.07%	34,000 $3.52 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3.37 Million - $3.97 Million	41,000 New	41,000 $3.48 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $7,791 - $9,466	-109 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $4.12 Million - $5.25 Million	-57,378 Reduced 99.81%	109 $10,000
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $2.47 Million - $2.82 Million	33,000 Added 134.77%	57,487 $4.44 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $1.84 Million - $2.07 Million	24,378 Added 22365.14%	24,487 $2.04 Million
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $64,940 - $78,809	-869 Reduced 88.85%	109 $8,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $71,012 - $88,215	978 New	978 $86,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.53 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.3 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.27 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$936 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$707 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account